Pdt Partners, LLC Ac Immune Sa Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $140,519 - $219,943	-29,093 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $29,760 - $40,032	-4,800 Reduced 14.16%	29,093 $195,000
Q2 2021 Aug 16, 2021	SELL	$6.04 - $8.37 $17,558 - $24,331	-2,907 Reduced 7.9%	33,893 $269,000
Q1 2021 May 17, 2021	SELL	$5.32 - $8.96 $99,696 - $167,910	-18,740 Reduced 33.74%	36,800 $280,000
Q4 2020 Feb 16, 2021	BUY	$4.47 - $5.58 $101,160 - $126,280	22,631 Added 68.77%	55,540 $287,000

Q3 2020 Nov 16, 2020	BUY	$4.78 - $9.06 $54,950 - $104,153	11,496 Added 53.69%	32,909 $161,000
Q2 2020 Aug 14, 2020	BUY	$6.57 - $8.3 $140,683 - $177,727	21,413 New	21,413 $144,000

29M

92.9K

46.3K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $323M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.